公开(公告)号：EP2124938A4

公开(公告)日：2010-04-14

申请号：EP08724001

申请日：2008-01-22

申请人： BOMAC RESEARCH LTD

发明人： NANJAN KARTHIGEYAN ,  AL ALAWI FADIL ,  CHAMBERS PAUL ,  HILL KATE

IPC分类号： A61K31/4164 ,  A61P5/14 ,  A61P5/16

CPC分类号： A61K31/4164 ,  A61K9/0017 ,  A61K47/10 ,  A61K47/12 ,  A61K47/22 ,  A61K47/34

摘要： The invention relates to composition and related therapeutic methods including at least one antihyperthyroid drug formulated for transdermal administration. Because the formulation is formulated for transdermal administration, the formulation is easier to administer than existing formulations which are administered orally to animals. Issues surrounding transdermal administration versus oral administration have also been resolved allowing the agent to remain stable during storage and retain a high level of efficacy.